Table 1 Common downregulated genes in hepatocellular carcinoma tumors and cell lines from transcriptional profiling
Cytoband | Accession no. | Name | Symbol | 20 Tumors | 20 Cell lines | ||
|---|---|---|---|---|---|---|---|
Median fold reduction | Percentage cases ≥3-fold (%) | Median fold reduction | Percentage cases ≥3-fold (%) | ||||
1p13.3 | Vav 3 oncogene | VAV3 | 3.50 | 53 | 3.48 | 67 | |
1p12 | 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 | HMGCS2 | 3.59 | 60 | 6.89 | 80 | |
1q42.2 | Angiotensinogen | AGT | 4.10 | 55 | 9.20 | 75 | |
2p24.1 | Apolipoprotein B | APOB | 3.59 | 60 | 3.24 | 50 | |
2p22.2 | CCAAT/enhancer binding protein zeta | CEBPZ | 4.28 | 60 | 3.76 | 75 | |
3p24.2 | N-glycanase 1 | NGLY1 | 4.01 | 68 | 3.15 | 60 | |
3q21.3 | MCM2 minichromosome maintenance deficient 2 | MCM2 | 4.70 | 65 | 5.58 | 74 | |
3q24–q25.1 | Ceruloplasmin | CP | 6.35 | 75 | 12.25 | 95 | |
3q25.1 | Transmembrane 4 superfamily member 4 | TM4SF4 | 3.30 | 56 | 3.35 | 53 | |
3q25.32 | G elongation factor, mitochondrial 1 | GFM1 | 5.08 | 77 | 28.71 | 100 | |
* 4q13.3 | Vitamin D binding protein | GC | 7.37 | 74 | 10.15 | 67 | |
* 4q31.3 | Fibrinogen gamma chain | FGG | 11.79 | 93 | 52.54 | 100 | |
4q32.1 | Tryptophan 2,3-dioxygenase | TDO2 | 3.06 | 50 | 4.56 | 67 | |
5p13.2 | LMBR1 domain containing 2 | LMBRD2 | 4.91 | 94 | 6.63 | 100 | |
6p21.33 | Apolipoprotein M | APOM | 3.11 | 50 | 5.12 | 68 | |
6p12.2 | Glutathione S-transferase A2 | GSTA2 | 4.00 | 67 | 6.36 | 95 | |
7p15.3 | Oxysterol binding protein-like 3 | OSBPL3 | 7.52 | 65 | 3.51 | 50 | |
7q22.1 | Cytochrome P450, family 3, subfamily A, polypeptide 7 | CYP3A7 | 5.85 | 56 | 13.87 | 92 | |
* 8p22–p21.3 | Fibrinogen-like 1 | FGL1 | 4.31 | 53 | 10.88 | 80 | |
8q12.1 | RAB2, member RAS oncogene family | RAB2 | 3.33 | 62 | 3.16 | 55 | |
10q26.3 | Mitochondrial short-chain enoyl-coenzyme A | ECHS1 | 3.58 | 63 | 3.06 | 58 | |
11p15.4 | Beta globin | HBB | 5.44 | 74 | 7.64 | 93 | |
11p15.1 | Serum amyloid A2 | SAA1 | 3.10 | 55 | 3.77 | 65 | |
12q13.3 | Hydroxysteroid dehydrogenase | RODH | 5.02 | 58 | 12.31 | 95 | |
12q21.33 | Decorin | DCN | 7.30 | 75 | 13.21 | 77 | |
12q24.13 | Serine dehydratase | SDS | 6.48 | 69 | 8.34 | 90 | |
14q12 | Syntaxin binding protein 6 | STXBP6 | 3.56 | 64 | 3.49 | 57 | |
* 16q12.2 | Metallothionein 1G | MT1G | 9.29 | 75 | 3.10 | 60 | |
* 17p13.3 | Alpha-2-plasmin inhibitor | SERPINF2 | 4.71 | 55 | 7.69 | 90 | |
17q11.2 | Vitronectin | VTN | 11.96 | 75 | 7.23 | 78 | |
17q23.2 | Myotubularin related protein 4 | MTMR4 | 7.17 | 93 | 5.45 | 80 | |
18q12.1 | Ring finger protein 138 | RNF138 | 12.15 | 68 | 7.55 | 95 | |
19q13.33 | Activating transcription factor 5 | ATF5 | 5.21 | 65 | 5.36 | 80 | |
20p12.3 | Proliferating cell nuclear antigen | PCNA | 3.34 | 57 | 4.09 | 67 | |
20q11.23 | Transglutaminase 2 | TGM2 | 4.66 | 70 | 3.01 | 53 | |